메뉴 건너뛰기




Volumn 298, Issue 9, 2007, Pages 457-463

Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis

Author keywords

Alefacept; Corticosteroids; Epidermal proliferation and differentiation; Psoriasis; T cell subsets

Indexed keywords

ALEFACEPT; BETAMETHASONE DIPROPIONATE; CD161 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; CORTICOSTEROID; DRUG VEHICLE; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; KI 67 ANTIGEN; NATURAL KILLER CELL RECEPTOR;

EID: 33846444695     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-006-0716-7     Document Type: Article
Times cited : (12)

References (29)
  • 1
    • 0034049874 scopus 로고    scopus 로고
    • Glucocorticoids in T cell development and function
    • Ashwell JD, Lu FW, Vacchio MS (2000) Glucocorticoids in T cell development and function. Annu Rev Immunol 18: 309-345
    • (2000) Annu Rev Immunol , vol.18 , pp. 309-345
    • Ashwell, J.D.1    Lu, F.W.2    Vacchio, M.S.3
  • 4
    • 22944458547 scopus 로고    scopus 로고
    • Plaque psoriasis vs. atopic dermatitis and lichen planus: A comparison for lesional T-cell subsets, epidermal proliferation and differentiation
    • Bovenschen HJ, Seyger MM, Van de Kerkhof PC (2005) Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation. Br J Dermatol 153:72-78
    • (2005) Br J Dermatol , vol.153 , pp. 72-78
    • Bovenschen, H.J.1    Seyger, M.M.2    Van de Kerkhof, P.C.3
  • 5
    • 16444375448 scopus 로고    scopus 로고
    • Selective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment
    • Bovenschen HJ, Vissers WH, Seyger MM, Van de Kerkhof PC (2005) Selective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment. Acta Derm Venereol 85:113-117
    • (2005) Acta Derm Venereol , vol.85 , pp. 113-117
    • Bovenschen, H.J.1    Vissers, W.H.2    Seyger, M.M.3    Van de Kerkhof, P.C.4
  • 7
    • 0028958047 scopus 로고
    • Effects of topical treatment with budesonide on parameters for epidermal proliferation, keratinization and inflammation in psoriasis
    • De Jong EM, Ferrier CM, de Zwart A, Wauben-Penris PJ, Korstanje C, Van de Kerkhof PC (1995) Effects of topical treatment with budesonide on parameters for epidermal proliferation, keratinization and inflammation in psoriasis. J Dermatol Sci 9:185-194
    • (1995) J Dermatol Sci , vol.9 , pp. 185-194
    • De Jong, E.M.1    Ferrier, C.M.2    de Zwart, A.3    Wauben-Penris, P.J.4    Korstanje, C.5    Van de Kerkhof, P.C.6
  • 8
    • 16444369820 scopus 로고    scopus 로고
    • Corticosteroids
    • Van de Kerkhof PCM ed, 2nd edn. Blackwell, Oxford
    • Eisman S, Rustin MH (2003) Corticosteroids. In: Van de Kerkhof PCM (ed) Textbook of psoriasis 2nd edn. Blackwell, Oxford
    • (2003) Textbook of psoriasis
    • Eisman, S.1    Rustin, M.H.2
  • 9
    • 0035954670 scopus 로고    scopus 로고
    • Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes
    • Ellis CN, Krueger GG (2001) Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med 345:248-255
    • (2001) N Engl J Med , vol.345 , pp. 248-255
    • Ellis, C.N.1    Krueger, G.G.2
  • 10
    • 0014985464 scopus 로고
    • The effect of corticosteroids on human epidermal mitotic activity
    • Fisher LB, Maibach HI (1971) The effect of corticosteroids on human epidermal mitotic activity. Arch Dermatol 103:39-41
    • (1971) Arch Dermatol , vol.103 , pp. 39-41
    • Fisher, L.B.1    Maibach, H.I.2
  • 11
    • 0018099294 scopus 로고
    • Severe psoriasis - oral therapy with a new retinoid
    • Frederiksson T, Petterson U (1978) Severe psoriasis - oral therapy with a new retinoid. Dermatologica 157:238-244
    • (1978) Dermatologica , vol.157 , pp. 238-244
    • Frederiksson, T.1    Petterson, U.2
  • 13
    • 0348134794 scopus 로고    scopus 로고
    • Treatment of psoriasis with alefacept. Correlation of clinical improvement with reductions of memory T-cell counts
    • Gordon KB, Vaishnaw AK, O'Gorman J, Haney J, Menter A (2003) Treatment of psoriasis with alefacept. Correlation of clinical improvement with reductions of memory T-cell counts. Arch Dermatol 139:1563-1570
    • (2003) Arch Dermatol , vol.139 , pp. 1563-1570
    • Gordon, K.B.1    Vaishnaw, A.K.2    O'Gorman, J.3    Haney, J.4    Menter, A.5
  • 16
    • 2142829675 scopus 로고    scopus 로고
    • Alefacept selectively reduces subpopulations of memory CD4+ and CD8+ T cells (Abstract)
    • Krueger JG, Gilleaudeau P, Kikuchi T, Lee E. (2002) Alefacept selectively reduces subpopulations of memory CD4+ and CD8+ T cells (Abstract). J Invest Dermatol 119:759
    • (2002) J Invest Dermatol , vol.119 , pp. 759
    • Krueger, J.G.1    Gilleaudeau, P.2    Kikuchi, T.3    Lee, E.4
  • 17
    • 0036145337 scopus 로고    scopus 로고
    • The immunologic basis for the treatment of psoriasis with new biologic agents
    • Krueger JG (2002) The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 46:1-23
    • (2002) J Am Acad Dermatol , vol.46 , pp. 1-23
    • Krueger, J.G.1
  • 18
    • 0037592156 scopus 로고    scopus 로고
    • Clinical response to alefacept: Results of a phase 3 study of intravenous administration of alefacept in patients with chronic plaque psoriasis
    • Krueger GG (2003) Clinical response to alefacept: results of a phase 3 study of intravenous administration of alefacept in patients with chronic plaque psoriasis. J Eur Acad Dermatol Venereol 2 (suppl 17):17-24
    • (2003) J Eur Acad Dermatol Venereol , vol.2 , Issue.SUPPL. 17 , pp. 17-24
    • Krueger, G.G.1
  • 19
    • 0036895587 scopus 로고    scopus 로고
    • Krueger GG, Papp KA, Stough DB, Loven KH, Gulliver WP, Ellis CN; Alefacept Clinical Study Group (2002) A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol 47:821-833
    • Krueger GG, Papp KA, Stough DB, Loven KH, Gulliver WP, Ellis CN; Alefacept Clinical Study Group (2002) A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol 47:821-833
  • 20
    • 0038385972 scopus 로고    scopus 로고
    • Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE; Alefacept Clinical Study Group (2003) An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Arch Dermatol 139:719-727
    • Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE; Alefacept Clinical Study Group (2003) An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Arch Dermatol 139:719-727
  • 21
    • 0028351526 scopus 로고
    • Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses. Structure/ function analysis in vitro and in human CD2 transgenic mice
    • Majeau GR, Meier W, Jimmo B, Kioussis D, Hochman PS (1994) Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses. Structure/ function analysis in vitro and in human CD2 transgenic mice. J Immunol 152:2753-2767
    • (1994) J Immunol , vol.152 , pp. 2753-2767
    • Majeau, G.R.1    Meier, W.2    Jimmo, B.3    Kioussis, D.4    Hochman, P.S.5
  • 22
    • 0027163180 scopus 로고
    • Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses
    • Miller GT, Hochman PS, Meier W, Tizard R, Bixler SA, Rosa MD, Wallner BP (1993) Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses. J Exp Med 178:211-222
    • (1993) J Exp Med , vol.178 , pp. 211-222
    • Miller, G.T.1    Hochman, P.S.2    Meier, W.3    Tizard, R.4    Bixler, S.A.5    Rosa, M.D.6    Wallner, B.P.7
  • 23
    • 0032847323 scopus 로고    scopus 로고
    • The immunologic and genetic basis of psoriasis
    • Nickoloff BJ (1999) The immunologic and genetic basis of psoriasis. Arch Dermatol 135:1104-10
    • (1999) Arch Dermatol , vol.135 , pp. 1104-1110
    • Nickoloff, B.J.1
  • 24
    • 0033748019 scopus 로고    scopus 로고
    • Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model
    • Nickoloff BJ, Bonish B, Huang BB, Porcelli SA (2000) Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model. J Dermatol Sci 24:212-225
    • (2000) J Dermatol Sci , vol.24 , pp. 212-225
    • Nickoloff, B.J.1    Bonish, B.2    Huang, B.B.3    Porcelli, S.A.4
  • 25
    • 0037930034 scopus 로고    scopus 로고
    • Clinical response to alefacept: Results of a phase 3 study of intramuscular administration of alefacept in patients with chronic plaque psoriasis
    • Ortonne JP (2003) Clinical response to alefacept: results of a phase 3 study of intramuscular administration of alefacept in patients with chronic plaque psoriasis. J Eur Acad Dermatol Venereol 2 (suppl 17):12-16
    • (2003) J Eur Acad Dermatol Venereol , vol.2 , Issue.SUPPL. 17 , pp. 12-16
    • Ortonne, J.P.1
  • 26
    • 0032845371 scopus 로고    scopus 로고
    • Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: An immunohistochemical study on remission and relapse
    • Van der Vleuten CJ, Van Vlijmen-Willems IM, De Jong EM, Van de Kerkhof PC (1999) Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse. Arch Dermatol Res 291:390-395
    • (1999) Arch Dermatol Res , vol.291 , pp. 390-395
    • Van der Vleuten, C.J.1    Van Vlijmen-Willems, I.M.2    De Jong, E.M.3    Van de Kerkhof, P.C.4
  • 27
    • 1342347762 scopus 로고    scopus 로고
    • The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis
    • Vissers WH, Berends M, Muys L, Van Erp PE, De Jong EM, Van de Kerkhof PC (2004) The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis. Exp Dermatol 13:106-112
    • (2004) Exp Dermatol , vol.13 , pp. 106-112
    • Vissers, W.H.1    Berends, M.2    Muys, L.3    Van Erp, P.E.4    De Jong, E.M.5    Van de Kerkhof, P.C.6
  • 29
    • 3042697256 scopus 로고    scopus 로고
    • Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late
    • Vissers WH, Arndtz CH, Muys L, Van Erp PE, de Jong EM, van de Kerkhof PC (2004) Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late. Br J Dermatol 150:852-859
    • (2004) Br J Dermatol , vol.150 , pp. 852-859
    • Vissers, W.H.1    Arndtz, C.H.2    Muys, L.3    Van Erp, P.E.4    de Jong, E.M.5    van de Kerkhof, P.C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.